None of the clinical parameters, including age, sex, smoking habit, tumor size, and stage, were correlated with PD-L1 immunoexpression, whereas there was a significant association between PD-L1-positive status and more aggressive thymomas (types B2 and B3). Here, CD274 is linked to thymoma.